NCT03305848View on ClinicalTrials.gov

Esophageal Food Impaction

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

April 4, 2019

Study Completion Date

April 4, 2019

Conditions
Esophageal Food Bolus Obstruction
Interventions
DRUG

Nitrostat 0.4Mg Sublingual Tablet

Up to 3 administrations of 0.4mg sublingual nitroglycerin tablets, dissolved in 10mL tap water, given orally in a single swallow. Each administration is separated by at least 5 minutes, and only if systolic blood pressure \> 100 mmHg.

Trial Locations (1)

55101

Regions Hospital, Saint Paul

All Listed Sponsors
lead

HealthPartners Institute

OTHER

NCT03305848 - Esophageal Food Impaction | Biotech Hunter | Biotech Hunter